|
|
|
|
|
|
Celldex Therapeutics (CLDX)
|
|
2.5501 +0.0401 (+1.5976%)
|
6/28/2017 1:16pm
|
|
Open:
|
2.5300
|
Pre. Close:
|
2.5100
|
|
High:
|
2.5800
|
Low:
|
2.4600
|
|
Volume:
|
525,389
|
Market Cap:
|
319.03M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.67 - 2.73
|
2.73 - 2.8
|
|
Low:
|
2.41 - 2.44
|
2.44 - 2.49
|
|
Close:
|
2.44 - 2.52
|
2.52 - 2.61
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-28 12:51:34 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 3.28  One year: 3.71
|
|
Support:
|
Support1: 2.20 Support2: 1.83
|
|
Resistance:
|
Resistance1:
2.81 Resistance2: 3.18
|
|
Pivot:
|
2.43
|
|
Moving Averages:
|
MA(5): 2.58  MA(20): 2.54
MA(100): 3.17 MA(250): 3.62
|
|
MACD:
|
MACD(12,26):
-0.12 Signal(12,26,9): -0.16
|
|
%K %D:
|
%K(14,3): 56.18 %D(3): 54.28
|
|
RSI:
|
RSI(14): 44.31
|
|
52-Week:
|
High: 5.0200
Low: 2.2000 Change(%): -41.1
|
|
Average Vol(K):
|
3-Month: 86074
10-Days 1833
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.CLDX has closed below upper band by 24.0%. Bollinger Bands are 0.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Thu, 01 Jun 2017 13:30:00 GMT
Celldex Therapeutics, Inc.: The Bear Case from a Bull
Tue, 06 Jun 2017 20:48:45 GMT
Here's Why Celldex Therapeutics, Inc. Fell Today
Fri, 16 Jun 2017 12:00:00 GMT
Celldex Therapeutics Announces Additions to the Board of Directors and Senior ...
Mon, 05 Jun 2017 20:26:15 GMT
Celldex Therapeutics Presents Phase 1 Study of Varlilumab and Opdivo® at 2017 ...
Wed, 28 Jun 2017 05:25:26 GMT
A Look at Valuation For Shares of Celldex Therapeutics, Inc. (NasdaqGS:CLDX)
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
